Breaking News

ICON, DIA in Webinar Series Pact

February 11, 2013

To provide solutions aimed at overcoming development challenges

ICON has entered into a collaboration with the Drug Information Assocation (DIA) to offer a webinar series providing free access to knowledge and innovative solutions aimed at overcoming some of the key challenges in medical product development.
ICON is the first to collaborate with DIA’s newly-created Solution Provider Webinar Program. ICON experts, along with scientists and thought leaders from the industry, will present four 90-minute webinars throughout 2013. The webinars are free to DIA members and will include topics such as oncology, strategies for late phase development, and biomarkers and technology in clinical development.
Mr. Robert L. Howie, Jr., chief marketing officer at ICON said, “We are delighted to work with an organization as respected as DIA to share and disseminate the industry insights we have gained from more than 20 years of helping biopharma companies bring their drugs to market faster. The webinars will discuss some of the burning challenges faced by our customers today and how ICON is bringing new ways of thinking as well as innovative solutions to help them overcome these challenges.”
Susan Cantrell, director, North America at DIA, said, “As the global forum for knowledge exchange, we are very excited to be launching our new Solution Provider Webinar program. The program, supported by companies like ICON, is intended to bring their solutions and experience to DIA members. Having expert presenters from both the solution-provider and industry perspectives ensures that these webinars will meet the high-quality standards that DIA members have come to expect.”
The first webinar, Oncology Clinical Trial Endpoints – Keys to Maximizing Success in your Development Programs, will take place on March 11, 2013.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks